Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature

The use of Rho Kinase (ROCK) inhibitors as therapeutic agents in ophthalmology has been a topic of discussion for several years, particularly in the realm of glaucoma, Fuchs’ endothelial dystrophy, and diabetic retinopathy. In this review, the authors provide a detailed and comprehensive overview of...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Med Hypothesis Discov Innov Ophthalmol
Главные авторы: Moshirfar, Majid, Parker, Lawsen, Birdsong, Orry C., Ronquillo, Yasmyne C., Hofstedt, Daniel, Shah, Tirth J., Gomez, Aaron T., Hoopes, Phillip C Sr.
Формат: Artigo
Язык:Inglês
Опубликовано: Medical Hypothesis, Discovery & Innovation Ophthalmology 2018
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6205677/
https://ncbi.nlm.nih.gov/pubmed/30386798
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы